Lisa R Hamrick1, Amanda Seidl2, Bridgette L Tonnsen1. 1. Department of Psychological Sciences, Purdue University, West Lafayette, Indiana. 2. Speech, Language, & Hearing Sciences, Purdue University, West Lafayette, Indiana.
Abstract
Fragile X syndrome (FXS) is a neurogenetic syndrome characterized by cognitive impairments and high rates of autism spectrum disorder (ASD). FXS is often highlighted as a model for exploring pathways of symptom expression in ASD due to the high prevalence of ASD symptoms in this population and the known single-gene cause of FXS. Early vocalization features-including volubility, complexity, duration, and pitch-have shown promise in detecting ASD in idiopathic ASD populations but have yet to be extensively studied in a population with a known genetic cause for ASD such as FXS. Investigating early trajectories of these features in FXS may inform our limited knowledge of potential mechanisms that predict later social communication outcomes. The present study addresses this need by presenting preliminary findings which (a) characterize early vocalization features in FXS relative to low-risk controls (LRC) and (b) test the specificity of associations between these features and language and ASD outcomes. We coded vocalization features during a standardized child-examiner interaction for 39 nine-month-olds (22 FXS, 17 LRC) whose clinical outcomes were assessed at 24 months. Our results provide preliminary evidence that within FXS, associations between vocalization features and 24-month language outcomes may diverge from those observed in LRC, and that vocalization features may be associated with later ASD symptoms. These findings provide a starting point for more research exploring these features as potential early markers of ASD in FXS, which in turn may lead to improved early identification methods, treatment approaches, and overall well-being of individuals with ASD. Autism Res2019.
Fragile X syndrome (FXS) is a neurogenetic syndrome characterized by cognitive impairments and high rates of autism spectrum disorder (ASD). FXS is often highlighted as a model for exploring pathways of symptom expression in ASD due to the high prevalence of ASD symptoms in this population and the known single-gene cause of FXS. Early vocalization features-including volubility, complexity, duration, and pitch-have shown promise in detecting ASD in idiopathic ASD populations but have yet to be extensively studied in a population with a known genetic cause for ASD such as FXS. Investigating early trajectories of these features in FXS may inform our limited knowledge of potential mechanisms that predict later social communication outcomes. The present study addresses this need by presenting preliminary findings which (a) characterize early vocalization features in FXS relative to low-risk controls (LRC) and (b) test the specificity of associations between these features and language and ASD outcomes. We coded vocalization features during a standardized child-examiner interaction for 39 nine-month-olds (22 FXS, 17 LRC) whose clinical outcomes were assessed at 24 months. Our results provide preliminary evidence that within FXS, associations between vocalization features and 24-month language outcomes may diverge from those observed in LRC, and that vocalization features may be associated with later ASD symptoms. These findings provide a starting point for more research exploring these features as potential early markers of ASD in FXS, which in turn may lead to improved early identification methods, treatment approaches, and overall well-being of individuals with ASD. Autism Res2019.
Authors: Catherine Lord; Eva Petkova; Vanessa Hus; Weijin Gan; Feihan Lu; Donna M Martin; Opal Ousley; Lisa Guy; Raphael Bernier; Jennifer Gerdts; Molly Algermissen; Agnes Whitaker; James S Sutcliffe; Zachary Warren; Ami Klin; Celine Saulnier; Ellen Hanson; Rachel Hundley; Judith Piggot; Eric Fombonne; Mandy Steiman; Judith Miles; Stephen M Kanne; Robin P Goin-Kochel; Sarika U Peters; Edwin H Cook; Stephen Guter; Jennifer Tjernagel; Lee Anne Green-Snyder; Somer Bishop; Amy Esler; Katherine Gotham; Rhiannon Luyster; Fiona Miller; Jennifer Olson; Jennifer Richler; Susan Risi Journal: Arch Gen Psychiatry Date: 2011-11-07
Authors: Sally Ozonoff; Gregory S Young; Alice Carter; Daniel Messinger; Nurit Yirmiya; Lonnie Zwaigenbaum; Susan Bryson; Leslie J Carver; John N Constantino; Karen Dobkins; Ted Hutman; Jana M Iverson; Rebecca Landa; Sally J Rogers; Marian Sigman; Wendy L Stone Journal: Pediatrics Date: 2011-08-15 Impact factor: 7.124
Authors: Florian B Pokorny; Maximilian Schmitt; Mathias Egger; Katrin D Bartl-Pokorny; Dajie Zhang; Björn W Schuller; Peter B Marschik Journal: Sci Rep Date: 2022-08-03 Impact factor: 4.996